文献速递神经肿瘤

全1p19q缺失胶质瘤的分子遗传学与临床病理预后因素:19p染色体获得和组织学分级III与患者预后负相关

Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis.
PubMed 文献 · J Neurooncol · 2016-12-26

该研究纳入1990至2010年间在庆应义塾大学医院手术的57例全1p19q缺失胶质瘤连续患者,评估染色体拷贝数异常、MGMT启动子甲基化及临床病理因素。年龄、切除程度、肿瘤最大径、组织学亚型和MGMT启动子甲基化状态与总生存无显著差异。19p染色体获得和组织学分级III与较短的总生存相关(P分别为0.019和0.061)。

要点

  • 在57例全1p19q缺失胶质瘤中,19p染色体获得与较短的总生存相关(P=0.019)。
  • 组织学分级III与较短的总生存相关(P=0.061)。
  • 年龄、切除程度、肿瘤最大径、组织学亚型和MGMT启动子甲基化状态与总生存无显著差异。

核心结论

  • 19p染色体获得和组织学分级III可能是全1p19q缺失胶质瘤患者的负面预后因素。
  • 需要进一步研究以证实这些观点。

研究设计与样本

  • 研究纳入1990年至2010年间在庆应义塾大学医院手术的57例全1p19q缺失胶质瘤连续患者。
  • 评估患者的染色体拷贝数异常、O6-甲基鸟嘌呤-DNA甲基转移酶基因(MGMT)启动子甲基化状态以及弥漫性胶质瘤的人口学和临床病理预后因素。

主要发现

  • 年龄(≥40岁 vs. <40岁)、切除程度、肿瘤最大径(≥5 cm vs. <5 cm)、组织学亚型和MGMT启动子甲基化状态在总生存(OS)方面无显著差异。
  • 19p染色体获得与较短的总生存相关(P = 0.019)。
  • 组织学分级III与较短的总生存相关(P = 0.061)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although 1p19q codeleted gliomas are the most favorable molecular subgroup of lower-grade gliomas, there are cases with early recurrence or short survival. The objective of this study was to elucidate molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss. The study included 57 consecutive patients with codeleted gliomas who were operated at Keio University Hospital between 1990 and 2010. These patients were assessed for chromosomal copy number aberrations, promoter methylation status of the O6-methylguanine-DNA methyltransferase gene (MGMT), and demographic and clinicopathological prognostic factors in diffuse gliomas. No significant difference was observed in the overall survival (OS) of the patients with respect to age (≥40 years vs. <40 years), degree of resection, maximum tumor diameter (≥5 cm vs. <5 cm), histological subtype, and MGMT promoter methylation status. Gain of chromosome 19p and grade III histology were associated with shorter OS (P = 0.019, 0.061, respectively). Gain of 19p and histological grade III might be negative prognostic factors for the patients with gliomas showing total 1p19q loss. Further investigation is warranted to confirm these notions.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Hayashi S, Kitamura Y, Hirose Y, et al. Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis. J Neurooncol. 2016. PMID: 28025770. doi:10.1007/s11060-016-2344-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。